These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1937570)

  • 41. Immunomodulation by interleukin-2 receptor targeted therapy.
    Gupta D; Naik S
    Natl Med J India; 1994; 7(2):67-70. PubMed ID: 8019399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-2 receptors on rat eosinophils in adjuvant arthritis.
    Meacock SC; Brandon DR; Smith W
    Immunology; 1991 Sep; 74(1):169-71. PubMed ID: 1937570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring of interleukin-2 receptor (IL-2R) expression in vivo and studies on an IL-2R-directed immunosuppressive therapy of active and adoptive adjuvant-induced arthritis in rats.
    Stünkel KG; Theisen P; Mouzaki A; Diamantstein T; Schlumberger HD
    Immunology; 1988 Aug; 64(4):683-9. PubMed ID: 3262576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
    Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
    Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical localization of cells reacting with monoclonal antibodies directed against the interleukin-2 receptor of murine, rat and human origin.
    Takacs L; Osawa H; Törö I; Diamantstein T
    Clin Exp Immunol; 1985 Jan; 59(1):37-44. PubMed ID: 3918819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models.
    Phadke K; Carlson DG; Gitter BD; Butler LD
    J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of interleukin 2 receptors on activated human B cells.
    Waldmann TA; Goldman CK; Robb RJ; Depper JM; Leonard WJ; Sharrow SO; Bongiovanni KF; Korsmeyer SJ; Greene WC
    J Exp Med; 1984 Nov; 160(5):1450-66. PubMed ID: 6092511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.
    Corvalan JR; Smith W
    Cancer Immunol Immunother; 1987; 24(2):127-32. PubMed ID: 3829046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
    Hancock WW; Muller WA; Cotran RS
    J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3.
    Birchenall-Sparks MC; Farrar WL; Rennick D; Kilian PL; Ruscetti FW
    Science; 1986 Jul; 233(4762):455-8. PubMed ID: 3088729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin 2 receptors on cultured murine epidermal Langerhans cells.
    Steiner G; Tschachler E; Tani M; Malek TR; Shevach EM; Holter W; Knapp W; Wolff K; Stingl G
    J Immunol; 1986 Jul; 137(1):155-9. PubMed ID: 3086446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts.
    Paterson DJ; Jefferies WA; Green JR; Brandon MR; Corthesy P; Puklavec M; Williams AF
    Mol Immunol; 1987 Dec; 24(12):1281-90. PubMed ID: 2828930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function?
    Tellides G; Dallman MJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):997-8. PubMed ID: 2650306
    [No Abstract]   [Full Text] [Related]  

  • 54. Differential regulation of the low affinity Fc receptor for IgE (Fc epsilon R2/CD23) and the IL-2 receptor (Tac/p55) on eosinophilic leukemia cell line (EoL-1 and EoL-3).
    Hosoda M; Makino S; Kawabe T; Maeda Y; Satoh S; Takami M; Mayumi M; Arai K; Saitoh H; Yodoi J
    J Immunol; 1989 Jul; 143(1):147-52. PubMed ID: 2525145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid and simple immunoperoxidase staining procedure for blood and bone marrow samples.
    Köller U; Stockinger H; Majdic O; Bettelheim P; Knapp W
    J Immunol Methods; 1986 Jan; 86(1):75-81. PubMed ID: 2418120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishment and characterization of a new human eosinophilic leukemia cell line.
    Saito H; Bourinbaiar A; Ginsburg M; Minato K; Ceresi E; Yamada K; Machover D; Bréard J; Mathé G
    Blood; 1985 Dec; 66(6):1233-40. PubMed ID: 2415185
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.